Minimizing Leukemia Escape: Implementing a Dual Anti-Cd20- and CD19-scFv-based Chimeric Antigen Receptor (CAR)
Journal for ImmunoTherapy of Cancer(2015)
摘要
Meeting abstracts Adoptive immunotherapy with chimeric antigen receptor (CAR) transduced T lymphocytes has shown promising results in both pediatric and adult B cell malignancies. Nevertheless, both CAR-based and antibody-based anti-CD19 therapies, e.g. blinatumomab, have seen treatment failures
更多查看译文
关键词
Flow Cytometric Analysis,Tumor Antigen,Chimeric Antigen Receptor,Adoptive Immunotherapy,CD20 Surface Marker
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要